The Inscripta™ Blog
March 30, 2021
Interested in Joining the Inscripta Team? We’re Hiring!
The Inscripta family is growing — fast. Our startup company is based on the idea that automating and scaling the CRISPR gene editing process…
March 26, 2021
Meet Infinome, the Newest Member of the Inscripta Family
We’re excited to announce that Inscripta now has its very first subsidiary company. We have invested in Infinome, a synthetic biology product…
March 23, 2021
Inscripta Expands Operations with New Office and Association Membership in Europe
Exciting news: Inscripta is heading to Europe! We are expanding operations beyond our U.S. base with a new office in Copenhagen, Denmark, to…
March 16, 2021
A New Digital Experience for Genome Engineering
As we designed the Onyx™ platform for automated genome engineering, we challenged ourselves to break free from the usual instrumentation and…
March 9, 2021
Scientists Deploy MAD7 Enzyme for Mammalian Genome Edits
Even before we launched our benchtop Onyx™ platform for automated genome engineering, the Inscripta team had already made progress in addressing…
March 2, 2021
Inside Inscripta: Patrick Westfall, Microbe
As we continue profiling members of the Inscripta team, we’re delighted to chat with Patrick Westfall, Senior Director, Microbe. The Illinois…
February 25, 2021
Onyx Platform Multiplexing Makes Full Saturation Protein Mutagenesis Possible
Picture it: You want to investigate your favorite biological phenomenon, and you start with a screening strategy that results in a number of…
February 16, 2021
Tackling Challenges in Today’s CRISPR Workflows
With so much enthusiasm around CRISPR gene editing, it’s all too easy to sweep aside those nagging concerns about technical implementation. But…
February 10, 2021
Inside Inscripta: Deanna Church, Mammalian Business Area
We hope you’re enjoying our employee profile series! Today we have the pleasure of catching up with Deanna Church, Vice President for Mammalian…